All stock lists
Rezolute, Inc. (NASDAQ:RZLT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
3.85-0.01 (-0.26%)
Insider Score
––Not scored
RZLT Insider Score
Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
RZLT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 8.00 K | 8.00 K | 7.00 K | 8.00 K | 0.00 | 0.00 |
| Gross Profit | -8.00 K | -8.00 K | -7.00 K | -8.00 K | 0.00 | 0.00 |
| SG&A Expense | 6.67 M | 5.95 M | 9.87 M | 6.79 M | 4.99 M | 4.74 M |
| R&D Expense | 14.89 M | 11.41 M | 14.35 M | 13.15 M | 20.86 M | 15.28 M |
| Operating Expenses | 21.56 M | 17.36 M | 24.21 M | 19.81 M | 25.85 M | 20.02 M |
| Operating Income | -21.56 M | -17.37 M | -24.22 M | -19.82 M | -25.85 M | -20.02 M |
| Pretax Income | -20.49 M | -16.17 M | -22.77 M | -18.15 M | -24.39 M | -18.91 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -20.49 M | -16.17 M | -22.77 M | -18.15 M | -24.39 M | -18.91 M |
| EPS (Basic) | -0.20 | -0.16 | -0.22 | -0.18 | -0.26 | -0.27 |
| EPS (Diluted) | -0.20 | -0.16 | -0.22 | -0.18 | -0.26 | -0.27 |
| Shares Outstanding | 104.49 M | 104.04 M | 103.69 M | 103.42 M | 94.34 M | 70.03 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.